Artikel

Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands

25.06.2025

Von Wiley-VCH zur Verfügung gestellt

There is no suitable radioligand for positron emission tomography imaging of CB2R overexpression for routine clinical usage. Herein, the synthesis, characterization, binding affinity, and docking studies of carborane-based halo-substituted naphthyridinone derivatives as CB2R ligands are presented. The meta-carborane derivatives are identified as the most affine CB2R ligands. Only small differences in selectivity to CB2R are observed for the iodo- and bromo-substituted meta-carborane derivatives.


The cannabinoid receptor type 2 (CB2R) is overexpressed under pathological conditions. Positron emission tomography is a noninvasive imaging technique for diagnosing disease states, but requires radiotracers with high affinity and selectivity towards CB2R. Currently, there is no suitable candidate routinely used in the clinics. The naphthyridinone scaffold, a promising core structure, has been modified in the past years. The modification of naphthyridinone carboxamides with carboranes as hydrophobic surrogates for purely organic moieties can lead to beneficial CB2R ligands with high affinity, selectivity, and metabolic stability. Herein, synthesis and characterization of eight ortho-, meta-, para-, and nido-carborane-based naphthyridinone ligands are reported, along with their in vitro binding affinity towards human CB1R and CB2R. Additionally, the results of in silico investigations are presented. The meta- and para-carborane derivatives show high affinity in the low nanomolar range and good selectivity towards CB2R. Only a minor influence of bromo- versus iodo-substitution of the compounds is observed experimentally, while in silico data suggest a stronger influence of the halogen atom, resulting in a different order of the respective carborane isomers regarding their CB2R affinity. Although these compounds do not outperform the known organic derivatives, these promising carborane-based naphthyridinones extend the portfolio of potentially useful CB2R ligands.

Verwandte Artikel
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
In Kürze
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
Ehrungen, Karriere
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
Aus den Fachgruppen
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
EuChemS Policy Workshop „PFAS”
Development of Carborane‐Based Halogenated Naphthyridinone‐Analogues as Cannabinoid Receptor Type 2 (CB2R) Ligands
Bafög beantragen

Das könnte Sie auch interessieren

GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

In Kürze

GÖCH

Termin vormerken: Generalversammlung am 21. September Die diesjährige Generalversammlung ist im Rahmen der Chemietage am...

30.04.2026
GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

Ehrungen, Karriere

Service

Ehrungen Finnian Freeling, Dr.: Promotionspreis Wasserchemie der Wasserchemischen Gesellschaft, Fachgruppe der GDCh, für...

30.04.2026
GDCh-Mitglieder exklusiv

Artikel • Nachrichten aus der Chemie

Aus den Fachgruppen

GDCh

Bauchemie Neuer Vorstand Die GDCh-Fachgruppe Bauchemie hat ihren Vorstand für die Amtszeit 1. Januar 2026 bis 31. Dezemb...

30.04.2026